在慢性新功能不全的临床治疗中,阻断RAS系统的活性是主要的治疗手段之一。传统的观念认为,ACEI是治疗慢性心功能不全的首选药物,但ARB问世后,有人认为ARB能取代ACEI,下面我将从它们的作用机制以及临床试验进行比较与综述。 Blocking the activity of the RAS system is one of the major treatments in the clinical treatment of chronic new-onset dysfunction. The traditional concept that ACEI is the treatment of chronic heart failure drug of choice, but after the advent of ARB, some people think that ARB can replace the ACEI, I will from their mechanism of action and clinical trials were compared and reviewed.